Beranda › Leukemia Mielomonositik Juvenil › New York
Uji klinis Leukemia Mielomonositik Juvenil di New York
3 studi untuk Leukemia Mielomonositik Juvenil mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1/2
1 Month – 21 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Menerima pesertaFase 1
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- dan 7 lainnya
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.